NCT04033939View on ClinicalTrials.gov

A Study Evaluating the Safety, Pharmacodynamics and Pharmacokinetics of HSK3486 in Healthy Subjects.

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

April 13, 2014

Primary Completion Date

November 11, 2014

Study Completion Date

May 4, 2015

Conditions
AnesthesiaSedation
Interventions
DRUG

HSK3486

DRUG

Propofol

DRUG

Placebo

All Listed Sponsors
lead

Sichuan Haisco Pharmaceutical Group Co., Ltd

INDUSTRY

NCT04033939 - A Study Evaluating the Safety, Pharmacodynamics and Pharmacokinetics of HSK3486 in Healthy Subjects. | Biotech Hunter | Biotech Hunter